Literature DB >> 18645923

Use of mouse models to study the role of tissue factor in tumor biology.

Rafal Pawlinski1, Nigel Mackman.   

Abstract

Tissue factor (TF) is the primary initiator of the coagulation cascade and plays an essential role in hemostasis. TF also contributes to many diseases, including cancer. The correlation between thrombosis and cancer has been recognized for more than a century. However, it is only in the past two decades that we have begun to understand the role of TF in tumor biology. TF expression is upregulated on both tumor and host cells in cancer patients as well as in the circulation. Clinical observations indicate a direct correlation between the levels of tumor cell TF expression and poor prognosis for cancer patients. The role of TF in tumor biology has been extensively studied using various mouse tumor models. It has been demonstrated that tumor cell TF contributes to tumor metastasis, growth, and angiogenesis. The role of host TF in tumor progression is less clear. Recently developed mouse models with altered levels of TF may be useful in further analysis of the role of host cell TF in cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18645923      PMCID: PMC2848503          DOI: 10.1055/s-2008-1079258

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  44 in total

Review 1.  Cancer modeling in the modern era: progress and challenges.

Authors:  Terry Van Dyke; Tyler Jacks
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

2.  Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.

Authors:  Gertrud M Hjortoe; Lars C Petersen; Tatjana Albrektsen; Brit B Sorensen; Peder L Norby; Samir K Mandal; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

3.  Tissue factor expression and prognosis in patients with metastatic prostate cancer.

Authors:  Takuya Akashi; Yuzo Furuya; Shoichiro Ohta; Hideki Fuse
Journal:  Urology       Date:  2003-12       Impact factor: 2.649

4.  Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.

Authors:  Todd A Hembrough; Glenn M Swartz; Adonia Papathanassiu; George P Vlasuk; William E Rote; Shawn J Green; Victor S Pribluda
Journal:  Cancer Res       Date:  2003-06-01       Impact factor: 12.701

5.  Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice.

Authors:  L A Snyder; K A Rudnick; R Tawadros; A Volk; S H Tam; G M Anderson; P J Bugelski; J Yang
Journal:  J Thromb Haemost       Date:  2007-11-14       Impact factor: 5.824

6.  Regulation of angiogenesis by tissue factor cytoplasmic domain signaling.

Authors:  Mattias Belting; Michael I Dorrell; Staffan Sandgren; Edith Aguilar; Jasimuddin Ahamed; Andrea Dorfleutner; Peter Carmeliet; Barbara M Mueller; Martin Friedlander; Wolfram Ruf
Journal:  Nat Med       Date:  2004-04-18       Impact factor: 53.440

7.  Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma.

Authors:  Ali Amirkhosravi; Todd Meyer; Jen-Yea Chang; Mildred Amaya; Farooq Siddiqui; Hina Desai; John L Francis
Journal:  Thromb Haemost       Date:  2002-06       Impact factor: 5.249

8.  Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma.

Authors:  Ronnie Tung-Ping Poon; Cecilia Pik-Yuk Lau; Joanna Wen-Ying Ho; Wan-Ching Yu; Sheung-Tat Fan; John Wong
Journal:  Clin Cancer Res       Date:  2003-11-01       Impact factor: 12.531

9.  Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

Authors:  Eric Camerer; Aisha A Qazi; Daniel N Duong; Ivo Cornelissen; Rommel Advincula; Shaun R Coughlin
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

10.  Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration.

Authors:  T Ueno; M Toi; M Koike; S Nakamura; T Tominaga
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

View more
  4 in total

1.  Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.

Authors:  Grace M Thomas; Laurence Panicot-Dubois; Romaric Lacroix; Françoise Dignat-George; Dominique Lombardo; Christophe Dubois
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

2.  Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.

Authors:  Marc Baud'huin; Laurence Duplomb; Stéphane Téletchéa; Céline Charrier; Mike Maillasson; Marc Fouassier; Dominique Heymann
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

3.  Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma.

Authors:  K-D Chen; C-C Wang; M-C Tsai; C-H Wu; H-J Yang; L-Y Chen; T Nakano; S Goto; K-T Huang; T-H Hu; C-L Chen; C-C Lin
Journal:  Cell Death Dis       Date:  2014-05-22       Impact factor: 8.469

4.  Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.

Authors:  Louise Tzung-Harn Hsieh; Scott J Dos Santos; Belinda S Hall; Joy Ogbechi; Aloysius D Loglo; Francisco Javier Salguero; Marie-Thérèse Ruf; Gerd Pluschke; Rachel E Simmonds
Journal:  PLoS Pathog       Date:  2022-01-31       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.